Flecainide monotherapy is an option for selected patients with catecholaminergic polymorphic ventricular tachycardia intolerant of β-blockade

Padfield, G. J., Alahmari, L., Lieve, K. V. V., Alahmari, T., Roston, T. M., Wilde, A. A., … Sanatani, S. (2016). Flecainide monotherapy is an option for selected patients with catecholaminergic polymorphic ventricular tachycardia intolerant of β-blockade. Heart Rhythm, 13(2), 609–613. https://doi.org/10.1016/j.hrthm.2015.09.027